Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi-center study.

Anke ZhangHoushi XuZeyu ZhangYibo LiuXiaying HanLing YuanYunjia NiShiqi GaoYuanzhi XuSheng ChenJunkun JiangYike ChenXiaotao ZhangMeiqing LouJian-Min Zhang

Published in: CNS neuroscience & therapeutics (2021)

This study demonstrated EMP3 as a novel predictor for clinical progression and clinical outcomes in glioma. Moreover, the nomogram with EMP3 expression represented a practical approach to provide individualized risk assessment for glioma patients.

Keyphrases

risk assessment
end stage renal disease
chronic kidney disease
newly diagnosed
poor prognosis
lymph node metastasis